Stock Events

Acadia Pharmaceuticals (ACAD) Q1 2014 Earnings

27FebConfirmed
May 13
Q3 2013
Q4 2013
Q1 2014
-0.13
-0.11
-0.1
-0.08

Details

Expected EPS
N/A
Actual EPS
-0.13
Surprise EPS
-0.13
Surprise Percent
+∞%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.13 per share for Q1 2014.

0 Comments

Share your thoughts